Furthermore, while the model utilizes easily accessible variables, the absence of more sophisticated biomarkers, such as serum myostatin or inflammatory markers, may restrict its ability to capture the complex biological processes driving sarcopenia. This evidence concerns the gene MSTN and sarcopenia.